Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-18-000109
Filing Date
2018-02-07
Accepted
2018-02-07 17:12:35
Documents
3
Group Members
ORBIMED CAPITAL GP V LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss79020_sc13da.htm SC 13D/A 97747
2 JOINT FILING AGREEMENT ss79020_ex9901.htm EX-99.1 23256
3 LOCK-UP AGREEMENT ss79020_ex9902.htm EX-99.2 26238
  Complete submission text file 0000947871-18-000109.txt   148879
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Subject) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90134 | Film No.: 18581901
SIC: 2834 Pharmaceutical Preparations